Sai‐Lan Liu

机构：Sun Yat-sen University, Shantou University, Marine Biology Institute of Shandong Province, Sun Yat-sen University Cancer Center

发表论文 71 篇 · 总被引 1306 次 · h-index 19

代表论文

• Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial (2023 · Nature Communications · 被引 50)
• Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial (2023 · The Lancet Oncology · 被引 41)
• Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial (2023 · European Journal of Cancer · 被引 33)
• Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma (2023 · BMC Cancer · 被引 16)
• Combined pre-treatment and middle-treatment Epstein–Barr virus DNA load contributes to prognostication and treatment modification in nasopharyngeal carcinoma patients (2024 · Therapeutic Advances in Medical Oncology · 被引 14)
• Seasonal changes of plankton community and its influencing factors in subtropical coastal marine areas revealed by eDNA-based network analysis (2024 · Frontiers in Marine Science · 被引 12)